Regeneron begins coronavirus antibody cocktail late-stage trial

A technician at Regeneron Pharmaceuticals headquarters in Tarrytown, New York.

Mike Segar | Reuters

Regeneron Pharmaceuticals mentioned on Monday it started late-stage medical trials to evaluate the effectiveness of its antibody cocktail in stopping and treating Covid-19.

The trial, run collectively with the National Institute of Allergy and Infectious Diseases, would check the remedy’s capability to forestall an infection in those that have had shut publicity to a Covid-19 affected person.

Source hyperlink

What do you think?

Written by Business Boy


Leave a Reply

Your email address will not be published. Required fields are marked *



Hundreds of scientists reportedly claim WHO is downplaying risk of airborne spread of coronavirus

Trump rips NASCAR for banning Confederate flag and targets Black driver Bubba Wallace